Skip to main
FDMT

FDMT Market Capitalization Overview

Market Cap: $428.52M as of Jan 9, 2026

$428.52M
$171.98M (28.64%)past month
As of Jan 9, 2026, FDMT has a market capitalization of $428.52M. Over the past 30 days, its market cap has decreased by -30.35%, while in the last 12 months, it has increased by 0%.

Market capitalization represents the total value of 4D Molecular Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

FDMT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of FDMT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FDMT Market Cap History

DateMarket CapChange
Dec 1, 2025$600.49M+14.60%
Nov 3, 2025$524.01M+28.52%
Oct 1, 2025$407.72M+42.18%
Sep 2, 2025$286.76M-3.58%
Aug 1, 2025$297.41M+54.70%
Jul 1, 2025$192.25M+10.67%
Jun 2, 2025$173.72M+9.06%
May 1, 2025$159.29M+15.05%
Apr 1, 2025$138.45M-27.66%
Mar 3, 2025$191.39M-30.19%
Feb 3, 2025$274.14M+1.72%
Jan 2, 2025$269.51M-23.19%

FDMT End of Year Market Cap History

DateMarket CapChange
2026$428.52M0.00%
2025$428.52M+66.42%
2024$257.49M-70.27%
2023$866.19M+20.40%
2022$719.44M+2.03%
2021$705.13M

FAQs About 4D Molecular Therapeutics (FDMT) Market Cap

As of Jan 9, 2026, the market capitalization of FDMT is $428.52M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, 4D Molecular Therapeutics’s market capitalization has decreased by -28.64%, changing from $600.49M to $428.52M as of Jan 9, 2026.

In the last 3 months, 4D Molecular Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, 4D Molecular Therapeutics’s market capitalization increased from $257.49M in January to $428.52M in December, reflecting a 66.42% change.

In the past five years, FDMT has had a compound annual growth rate (CAGR) of -9.48% in market capitalization. This means its market cap has shrunk at an average rate of -9.48% per year.

4D Molecular Therapeutics (FDMT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.